레어노트 icon

5.2.8 by Humanscape


Nov 4, 2024

About 레어노트

The fastest way to access rare disease information from around the world

● What kind of service is ‘Rare Note’?

If you are not sure what information is reliable and what is the most up-to-date information after being diagnosed with a rare disease, download RareNote. Rarenote, a rare disease information platform, delivers reliable information the fastest.

1. Global News

- You can receive news articles from major media outlets related to rare diseases at home and abroad in real time.

- For those who are unfamiliar with English, overseas articles are provided in Korean.

2. Disease information

- You can check the information you need to know after you are first diagnosed with a rare disease.

- We collect and deliver reliable basic disease knowledge provided by the domestic Korea Disease Control and Prevention Agency's helpline, overseas medical professional databases StatPearls, and MedlinePlus.

3. Clinical trial status

- Information from clinicaltrials.gov, an overseas clinical trial information database, is updated in real time.

- Check clinical trial information related to your disease, new drug development progress, and expected period until treatment approval.

4. Patient meeting information

- You can check and join patient meetings and detailed activities for your disease.

- Completing the health survey data conducted by Rarenote and the patient group provides an opportunity to raise awareness of your rare disease and share it with more people.

5. News

- We will provide you with new news about my disease, such as new events, campaigns, and seminars.

- If there is any news about my disease that only I know about, please let me know on Rare Note. We will post this in the ‘News’ section so that more patients can learn about it and participate.

6. Community

- If you have any questions about symptoms, prescriptions, medications, etc., ask the patient or guardian with the same disease.

- You can also receive real-time notifications of new posts from patients and guardians with the same disease as you.

● Why does ‘Rare Note’ do this?

Rare Note works to solve various problems for patients with rare diseases. Ultimately, our goal is to expand treatment opportunities for patients with rare diseases. Rare Note not only resolves the ‘lack of information’ for rare disease patients, but also contributes to expanding treatment opportunities for patients by working with patient groups, medical staff, etc. to build a data registry for each rare disease.

Related article: Humanscape joins hands with Hana Bank and the Korea Rare and Incurable Diseases Association to participate in the project to build rare disease ‘patient health data’ http://www.hitnews.co.kr/news/articleView.html?idxno=50922

Humanscape and the patient group 'Korea Multiple Sclerosis Association' are expanding treatment opportunities for the rare disease 'multiple sclerosis' http://www.hitnews.co.kr/news/articleView.html?idxno=46898

● Inquiries

Please send an email to [email protected]. The Rarenote team awaits various suggestions and opinions from medical staff, pharmaceutical companies, patient groups, and patients/guardians.

What's New in the Latest Version 5.2.8

Last updated on Nov 4, 2024

‘약제비 지원’ 기능의 사용성이 개선되었습니다.

약제비 지원 프로그램이란?
특정 질환에 한해, 주치의의 추천을 받은 환자 중 지원 기준을 충족하는 분들에게 후원사의 지원을 받아 약제비의 일부를 지원하는 프로그램입니다.
레어노트는 앞으로도 환자분들의 치료 기회를 넓히기 위해 다양한 서비스를 지속적으로 고민하고 제공할 예정입니다.
이번 업데이트를 통해 더 나은 서비스를 만나보세요.

Translation Loading...

Additional APP Information

Latest Version

Request 레어노트 Update 5.2.8

Uploaded by

Ãmm Hèñg Dëprø

Requires Android

Android 6.0+

Available on

Get 레어노트 on Google Play

Show More

레어노트 Screenshots

Comment Loading...
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.